androgen receptor estrogen receptor ginseng nuclear receptor steroid hormone receptor a b s t r a c t Ginseng has been used in China for at least two millennia and is now popular in over 35 countries. It is one of the world's popular herbs for complementary and alternative medicine and has been shown to have helpful effects on cognition and blood circulation, as well as anti-aging, anti-cancer, and antidiabetic effects, among many others. The pharmacological activities of ginseng are dependent mainly on ginsenosides. Ginsenosides have a cholesterol-like four trans-ring steroid skeleton with a variety of sugar moieties. Nuclear receptors are one of the most important molecular targets of ginseng, and reports have shown that members of the nuclear receptor superfamily are regulated by a variety of ginsenosides. Here, we review the published literature on the effects of ginseng and its constituents on two main sex steroid hormone receptors: estrogen and androgen receptors. Furthermore, we discuss applications for sex steroid hormone receptor modulation and their therapeutic efficacy.
Introduction
Ginseng has been used for over 2,000 y as a medicine in East Asia. It is a popular herb in the world, and is used in more than 35 countries as a food, health supplement, and natural remedy [1] . Ginseng has been demonstrated to have an extensive range of pharmacological effects on the reproductive, cardiovascular, endocrine, and immune systems. Its ability to diminish fatigue, enhance blood circulation, aid menopausal symptoms, boost immune function, and enhance concentration has been verified in certain countries [2] . Many components of ginseng, such as ginsenosides, polysaccharides, peptides, polyacetylenic alcohols, and fatty acids, have been isolated and characterized [3, 4] . However, further research is necessary to understand how these components contribute to ginseng's pharmacological properties. Among these constituents, dammarane-type ginsenosides, comprising a rigid steroid skeleton consisting of four transrings with a modified side chain at Ce20, have received considerable attention because of their biological activity [5, 6] . To date, more than 100 different ginsenosides with various pharmacological effects have been isolated and identified from the root of Panax ginseng, with ginsenosides Rb1, Rb2, Rg1, and Re being most abundant. In addition, steaming and drying during processing of ginseng can affect its pharmacological activity by altering the characteristics of the constituent ginsenosides [7e12] . Red ginseng, produced by steaming fresh ginseng, possesses unique ginsenosides (Rg3, Rg5, Rh2, Rh3, Rh4, Rs3, and F4) [13e15] .
The molecular target of ginsenosides may be located either in the cellular membrane or inside the cell, depending on the hydrophobicity of the ginsenoside [16] . Most ginsenosides are lipophilic in nature; with their steroidal backbone they can traverse cell membranes by simple diffusion, and regulate cellular functions by binding to specific intracellular target proteins in the cytoplasm and nucleus [16] . The nongenomic pathway of ginsenoside activity involves binding to membrane-associated receptors that initiate the activation of the phosphorylation cascade and generation of second messengers. Ginsenosides activate the genomic pathway by initially binding to intracellular nuclear hormone receptors, such as the glucocorticoid receptor, progesterone receptor, androgen receptor (AR), mineralocorticoid receptor, estrogen receptor (ER), peroxisome proliferator-activated receptor, and liver X receptor [17e29] . Many studies have shown that ginsenosides act through nuclear hormone receptors. For example, one study found that administration of ginseng extract for about 1.5 wk inhibited the activity of peroxisome proliferator-activated receptor-a and the expression of several genes associated with lipid and lipoprotein metabolism [30] ; presumably, ginsenosides were the active constituents. Ginsenosides enhanced the expression levels of glucocorticoid receptor in the brain cytosol of heat-injured rats [31] . In another study, the interaction of ginsenoside-activated glucocorticoid receptors triggered the activation of the phosphatidylinositol-3 kinase (PI3K)/Akt pathway and increased nitric oxide production in human umbilical vein endothelial cells [32] . Ginsenosides act through not only steroid hormone receptors, but also ion channels. One study showed that ginsenosides inhibit voltage-dependent calcium, potassium, and sodium channel activities in a stereospecific manner, and block subtypes of nicotinic acetylcholine and 5-hydroxytryptamine type 3 receptors [33] .
Here, we review the ginsenosides that affect estrogen and androgen activities, including those that directly or indirectly modulate ERs and ARs. We also discuss clinical studies of ginseng on female and male reproductive functions.
Effects on ERa and ERb

Genomic and nongenomic action
Estrogens are female steroid hormones that are produced mainly by the ovaries through the conversion of cholesterol. Estrogens can also be produced locally in the placenta, adrenal glands, adipose tissue, and brain, where they act in a paracrine fashion [34] . Estrogens are essential in the development and maintenance of the female reproductive system, immune system, cardiovascular system, and central and peripheral nervous systems; they also regulate bone metabolism [35] . As a consequence of their wide range of physiological roles, estrogens are also involved in many pathological states, including cancer, metabolic and cardiovascular diseases, neurodegeneration, and osteoporosis [36] .
Phytoestrogens are compounds of plant origin that can exert estrogenic properties, through either directly binding to ER or indirectly activating ERs [36e38]. Phytoestrogens, such as genistein and daidzein, have shown protective effects on conditions related to decreased estrogen, including menopause, osteoporosis, and cognitive disorders [39, 40] . The interest in the use of phytoestrogens stems from epidemiologic studies suggesting a decreased incidence of breast cancer, and lower occurrence and complaints of menopausal symptoms and osteoporosis in women from countries with high consumption of phytoestrogens, mainly found in soy products [41e44] .
Cellular effects of estrogens are mediated by ERs, which are transcription factors activated by ligands. Two distinct isoforms exist: ERa and ERb. The expression patterns of these two receptors differ and display distinct characteristics. ERa is expressed mainly in reproductive tissues such as the uterus and ovary, breast, bone, white adipose tissue, and liver. ERb is expressed mainly in the ovary, central nervous system, cardiovascular system, lung, prostate, colon, and the immune system [36, 45, 46] .
The classical estrogen action model suggests that nuclear ER changes its conformation upon ligand binding, binds to the cognate estrogen-responsive element, and modulates the transcription of target genes [47, 48] . Hundreds of coactivator/corepressor regulatory proteins affect the ER-mediated transcriptional response. ERs are mainly found in the nucleus and also in the cytoplasmic membrane. Estrogen binds to the membrane receptors and stimulates signaling proteins. The nongenomic pathway triggers G protein-coupled receptors, generates calcium flux, stimulates cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) production, and activates the PI3K and extracellular-signal-regulated kinase (ERK) pathways [49e51]. Recent researches indicate that ERs were also identified in mitochondria and endosomes, and that the act of signaling from all these sites must be integrated with nuclear ER action to produce the final 
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Rb1 -estrogenic activity, prevents apoptosis Rg1 -estrogenic activity, neuroprotective activity Rg3 -inhibits migration, NO production Re -activates cardiac potassium channels Rh1 -estrogenic activity R1 -anti-inflammation, stimulates osteoblast differentiation Ft1 -NO-mediated relaxation Ginsenosides Notoginsenosides Fig. 1 . Ginsenosides modulating estrogen receptor pathway. A summarized diagram of ginsenosides affecting the estrogen receptor pathway via genomic and nongenomic pathways. COX-2, cyclooxygenase-2; eNOS, endothelial nitric oxide synthase; ER, estrogen receptor; iNOS, inducible nitric oxide synthase; PI3K, phosphatidylinositol-3 kinase; NO, nitric oxide; MAPK, p38 mitogen-activated protein kinase; AMPK, AMP-activated protein kinase. AR, androgen receptor; COX-2, cyclooxygenase-2; ER, estrogen receptor; GR, glucocorticoid receptor; IL, interleukin; iNOS, inducible nitric oxide synthase; MMP-3, matrix metalloproteinase-3; NF-kB, nuclear factor-kB; NO, nitric oxide; PI3K, phosphatidylinositol-3 kinase; PPAR, peroxisome proliferator-activated receptor; 5-HT, 5-hydroxytryptamine functions of the steroid [52, 53] . Studies using a xenograft model of MCF-7 human breast cancer cells injected into nude mice have shown that engagement of only the membrane receptor by an estrogenic compound failed to stimulate tumor proliferation [54] . This indicates that nongenomic and genomic pathways of ER communicate, which is likely to play a role in promoting human breast tumor growth. Cellular effects of ginsenosides can be influenced by many factors, including concentration, receptor status, amount of endogenous estrogens, and target tissue [55] . Some phytoestrogens display different affinities to ER isoforms [56] . No study has shown antiestrogenic effects of ginsenosides, but both estrogenic and antiestrogenic activities have been reported for genistein [57, 58] . Treatment with P. ginseng upregulated both ERa and ERb in the reproductive organs (e.g., uterus and vagina) of both normal and ovariectomized mice, demonstrating that P. ginseng had a potent estrogenic activity [25, 26] . However, P. ginseng upregulated the expression of ERa to a greater extent than that of ERb in the uterus and vagina, suggesting that P. ginseng selectively binds to ERa in these reproductive tissues [25, 26] . However, ERb antagonizes ERamediated effects in reproductive tissues, such as the breast, ovary, prostate, and uterus [59, 60] . In contrast to the effects seen in reproductive organs, treatment of immobilized mice brains and in vitro treatment of neuroblastoma SK-N-SH cells with hydrogen peroxide depressed ERb, but not ERa [24] . Korean Red Ginseng (KRG) upregulates ERb and subsequently mitigates stress-induced gene expression [24] . Consistently, in vitro studies also demonstrated that KRG represses apoptosis by potentiating PI3K/Akt signaling via ERb upregulation [61, 62] . For instance, KRG appears to repress stress-induced tumor necrosis factor-a converting enzyme and nuclear factor-kB in immobilized mice brains and H 2 O 2 -induced neuroblastoma SK-N-SH cells, thus preventing the production of reactive oxygen species and protecting brain cells from apoptosis [24, 61, 62] . Thus, in the brain, ERb seems to inhibit apoptosis and antagonize oxidative stress.
Regarding the mechanisms of action of KRG components, the major ginsenoside Rb1 dose dependently activated both ERa and ERb in COS monkey kidney cells, but it did not bind to the ER receptors in MCF-7 breast cancer cells [63] . In contrast, the antiangiogenic effects of the ginsenoside Rb1 have been ascribed to its interaction with ERb in vitro. Rb1 specifically increased the expression of a potent antiangiogenic protein pigment epitheliumderived factor by binding to ERb, but not to ERa, resulting in the inhibition of endothelial tube formation [64] . These results suggest that KRG might affect ERb expression in a tissue-and organ-specific manner.
Reproduction is controlled mainly by estradiol in an ERadependent manner. Furthermore, brain functions are profoundly mediated by ERa, but not by ERb [65, 66] , and most research on ERb has focused on brain function and behavior [67] . However, in the brain, ERa and ERb are usually tightly controlled in an interrelated and estradiol-dependent manner for a particular brain function [67] . ERb modulation is also common; for example, hypernatremia stress and immobilization stress downregulate ERb expression [24, 68] . In contrast, P. ginseng may upregulate ERb in the brain, and ERb may counteract stress via antiapoptotic and antioxidative activities [24] . Although the underlying mechanism for this effect requires further study, one possible explanation is that KRG upregulates the steroidogenic enzyme P450 (Cyp11a1) [69] . Cyp11a1 catalyzes the initial and rate-limiting step in steroid hormone synthesis, and cleaves the cholesterol side chain into pregnenolone with a steroidogenic potential [70] . However, an interaction between ERa and ERb cannot be ruled out; further research on the interaction between these two proteins in the brain is therefore required to clarify the underlying mechanism. Table 1 summarizes the modulating effects of ginsenosides upon the ER pathway.
Clinical studies on menopausal symptoms, erectile dysfunction, and women's sexual function
Ginseng has often been used for management of menopausal symptoms in postmenopausal women, and sexual function in both men and women. One systematic review suggested that the evidence on efficacy of ginseng for managing menopausal symptoms was limited [89] . Three randomized controlled trials (RCTs), which were included in the review, tested the efficacy of KRG compared with placebo, and their results showed superior effects of KRG on sexual arousal and global health [90e92]. Another trial reported favorable effects of ginseng supplements on well-being and depression as compared with placebo [93] .
Regarding the efficacy of KRG for sexual function in men, one systematic review investigated the efficacy of KRG for erectile dysfunction (ED) compared with placebo [94] . This review included seven RCTs, and their results suggested superior effects of KRG on improvement of ED compared with placebo. Recently, two additional RCTs also reported positive effects of KRG on ED [95, 96] . Collectively, the evidence on the efficacy of KRG for treating ED is highly significant.
For the effects of KRG on women's sexual function, three crossover RCTs tested the efficacy of KRG for the sexual function of women compared with placebo control [90, 97, 98] . One RCT showed positive effects of KRG on sexual arousal [90] , and the other two RCTs reported improvement of sexual function without statistical significance compared with placebo control [97, 98] .
Effects on AR
Androgens mediate a wide range of male developmental processes, and are especially important in male sexual differentiation as well as pubertal maturation, maintenance of spermatogenesis, and male gonadotropin regulation [99] . Testosterone and its metabolite 5-a-dihydrotestosterone, two principal androgens, exert their function predominately through AR-mediated pathways [100] . Disorganization of the androgeneAR complex results in androgen insensitivity syndrome, eventually leading to dysfunctions of the male reproductive system, such as subfecundity or infertility. Defects in the AR lead to distinct signs of undervirilization and undermasculinization in males [101] . Disturbance of the androgeneAR complex is triggered mainly by mutations in the AR gene. Mutations in the AR gene are inherited in an X-linked recessive pattern and, therefore, affect males much more frequently than females [102] .
Melo et al [103] studied the relationship between male infertility and androgen AR mutations in Brazilian patients, and postulated that patients who do not produce sperm have a higher number of AR mutations than those with merely impaired sperm production.
While the expression level of AR itself, as well as luteinizing hormone receptor (LHR) and follicle-stimulating hormone receptor (FSHR), may also contribute to androgen insensitivity and male sub-and/or infertility, this idea has not received much scientific attention to date. This topic has largely been overlooked in the biochemical and pharmacological communities, as well as in urology. The expression levels of proteins and mRNAs for AR, LHR, and FSHR in testicular tissue from aged and doxorubicin-sensitized Sprague-Dawley rats, were significantly downregulated in these animals as well as in animals stress loaded by intermittent immobilization (2 h/d for 8 wk/6 mo) and heat (32 C, 2 h/d for 8 wk/6 mo). Pretreatment with KRG markedly prevented the downregulation of these receptors [104, 105] . Wang et al [106] , at the Center for Disease Prevention and Control in Shenyang Command, Shenyang, China, carried out a similar experiment in coldstressed rats. They reported that ginseng polysaccharides upregulated AR mRNA expression levels and promoted testosterone. These results indicate that P. ginseng plays an important role in maintaining healthy levels of steroid hormone receptors, including AR, which in turn ensures the proper functioning of androgens.
Conclusion
Ginseng has been used for various pathological problems, as well as for preventing and enhancing overall physiological functions. The effects of ginsengs in cancer chemoprevention and therapeutics are one of the most intensively studied areas. Identification of cellular targets responsible for such activity and characterization of active red ginseng compounds still requires continuous research. Nuclear hormone receptors are one of the cellular targets of ginsenosides that are lipophilic in nature. ER is one of the well-studied targets for ginsenosides among the members of nuclear steroid hormone receptors. Modulation of ERs by ginseng components can be beneficial to estrogen-dependent cancer and many physiological states deriving from low levels of estrogen hormones due to aging as well as inevitable ovary-related surgery in younger women. As shown, studies targeting ARs and androgen-associated physiological states are less studied. Even with accumulating data on estrogen-mimicking or supplemental activity of ginseng in humans, additional accumulative data are still required to establish and provide a scientific basis of ginseng use on sex steroid hormone-dependent function.
